Inhibition of human immunodeficiency virus type 1 infection in macrophages by an alpha-v integrin blocking antibody

Antiviral Research

Volumn 69, Issue 3, 2006, Pages 173-180

  Bosch, Berta ^a   Clotet Codina, Imma ^a   Blanco, Julià ^a   Pauls, Eduardo ^a   Coma, Gemma ^a   Cedeño, Samandhy ^a   Mitjans, Francesc ^b   Llano, Anuska ^a   Bofill, Margarita ^a   Clotet, Bonaventura ^a   Piulats, Jaume ^b   Esté, José A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Laboratorio de Bioinvestigación   (Spain)

Author keywords

alpha v; Anti HIV agents; HIV 1; Integrins; Macrophage colony stimulating factor; Macrophages

Indexed keywords

ALPHA V INTEGRIN ANTIBODY; ALPHAVBETA6 INTEGRIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; C 34; EM 409849; EMD 409849; GLYCOPROTEIN GP 41 INHIBITOR; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14D9.F8; MONOCLONAL ANTIBODY 17E6; MONOCLONAL ANTIBODY 5C4; PROTEIN INHIBITOR; RITONAVIR; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CHRONOPHARMACOLOGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOLECULAR WEIGHT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS DETECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELLS, CULTURED; DNA, VIRAL; HIV-1; HUMANS; INTEGRIN ALPHAV; INTEGRINS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; PROVIRUSES; RECEPTORS, HIV; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 32644469312     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.12.004     Document Type: Article

References (34)

1. S. Aquaro, P. Bagnarelli, T. Guenci, A. De Luca, M. Clementi, E. Balestra, R. Calio, and C.F. Perno Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus J. Med. Virol. 68 2002 479 488
2. S. Aquaro, T. Guenci, F. Di Santo, M. Francesconi, R. Calio, and C.F. Perno Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus Antiviral Res. 61 2004 133 137
3. M. Armand-Ugon, I. Clotet-Codina, C. Tintori, F. Manetti, B. Clotet, M. Botta, and J.A. Esté The anti-HIV activity of ADS-J1 targets the HIV-1 gp120 Virology 343 2005 141 149
4. M. Armand-Ugon, A. Gutierrez, B. Clotet, and J.A. Esté HIV-1 resistance to the gp41-dependent fusion inhibitor C-34 Antiviral Res. 59 2003 137 142
5. M. Armand-Ugon, M.E. Quinones-Mateu, A. Gutierez, J. Barretina, J. Blanco, D. Schols, E. De Clercq, B. Clotet, and J.A. Esté Reduced fitness of HIV-1 resistant to CXCR4 antagonists Antivir. Ther. 8 2003 1 8
6. E. Baranowski, C.M. Ruiz-Jarabo, and E. Domingo Evolution of cell recognition by viruses Science 292 2001 1102 1105
7. A. Bergamini, C.F. Perno, M. Capozzi, E. Mannella, A. Salanitro, R. Calio, and G. Rocchi A tetrazolium-based colorimetric assay for quantification of HIV-1-induced cytopathogenicity in monocyte-macrophages exposed to macrophage-colony-stimulating factor J. Virol. Methods 40 1992 275 286
8. A. Bergamini, C.F. Perno, L. Dini, M. Capozzi, C.D. Pesce, L. Ventura, L. Cappannoli, L. Falasca, G. Milanese, R. Calio, and G. Rocchi Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding Blood 84 1994 3405 3412
9. J. Blanco, B. Bosch, M.T. Fernandez-Figueras, J. Barretina, B. Clotet, and J.A. Esté High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells J. Biol. Chem. 279 2004 51305 51314
10. B. Bosch, J. Blanco, I. Clotet-Codina, E. Pauls, M. Armand-Ugon, B. Grigorov, D. Muriaux, B. Clotet, J. Darlix, and J.A. Esté Inhibition of coreceptor independent cell-to-cell HIV-1 transmission by a CD4-IgG2 fusion protein Antimicrob. Agents Chemother. 49 2005 4296 4304
11. T.W. Chun, R.T. Davey Jr., M. Ostrowski, J. Shawn Justement, D. Engel, J.I. Mullins, and A.S. Fauci Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy Nat. Med. 6 2000 757 761
12. M.O. De Nichilo, and G.F. Burns Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages Proc. Natl. Acad. Sci. U.S.A. 90 1993 2517 2521
13. J.A. Esté Virus entry as a target for anti-HIV intervention Curr. Med. Chem. 10 2003 1617 1632
14. J.A. Esté, C. Cabrera, E. De Clercq, S. Struyf, J. Van Damme, G. Bridger, R.T. Skerlj, M.J. Abrams, G. Henson, A. Gutierrez, B. Clotet, and D. Schols Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor Mol. Pharmacol. 55 1999 67 73
15. T.M. Folks, D. Powell, M. Lightfoote, S. Koenig, A.S. Fauci, S. Benn, A. Rabson, D. Daugherty, H.E. Gendelman, M.D. Hoggan, S. Venkatesan, and M.A. Martin Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus J. Exp. Med. 164 1986 280 290
16. M.F. Gruber, K.A. Weih, E.J. Boone, P.D. Smith, and K.A. Clouse Endogenous macrophage CSF production is associated with viral replication in HIV-1-infected human monocyte-derived macrophages J. Immunol. 154 1995 5528 5535
17. P.J. Hippenmeyer, P.G. Ruminski, J.G. Rico, H.S. Lu, and D.W. Griggs Adenovirus inhibition by peptidomimetic integrin antagonists Antiviral Res. 55 2002 169 178
18. R.O. Hynes Integrins: bidirectional, allosteric signaling machines Cell 110 2002 673 687
19. J. Kutza, L. Crim, S. Feldman, M.P. Hayes, M. Gruber, J. Beeler, and K.A. Clouse Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages J. Immunol. 164 2000 4955 4960
20. R.M. Lafrenie, S.F. Lee, I.K. Hewlett, K.M. Yamada, and S. Dhawan Involvement of integrin alphavbeta3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes Virology 297 2002 31 38
21. R.G. Lima, J. Van Weyenbergh, E.M. Saraiva, M. Barral-Netto, B. Galvao-Castro, and D.C. Bou-Habib The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells J. Infect. Dis. 185 2002 1561 1566
22. Y.L. Lin, C. Mettling, P. Portales, J. Reynes, J. Clot, and P. Corbeau Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection Proc. Natl. Acad. Sci. U.S.A. 99 2002 15590 15595
23. A. Llano, J. Barretina, A. Gutierrez, B. Clotet, and J.A. Esté Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression J. Virol. 77 2003 4389 4395
24. F. Mitjans, D. Sander, J. Adan, A. Sutter, J.M. Martinez, C.S. Jaggle, J.M. Moyano, H.G. Kreysch, J. Piulats, and S.L. Goodman An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice J. Cell. Sci. 108 1995 2825 2838
25. G. Moncunill, E. Negredo, L. Bosch, J. Vilarrasa, M. Witvrouw, A. Llano, B. Clotet, and J.A. Este Evaluation of the anti-HIV activity of statins AIDS 19 2005 1697 1700
26. C.F. Pereira, J.T. Paridaen, K. Rutten, M.C. Huigen, M. van de Bovenkamp, J. Middel, N. Beerens, B. Berkhout, R. Schuurman, L.J. Marnett, J. Verhoef, and H.S. Nottet Aspirin-like molecules that inhibit human immunodeficiency virus 1 replication Antiviral Res. 58 2003 253 263
27. C.F. Perno, F.M. Newcomb, D.A. Davis, S. Aquaro, R.W. Humphrey, R. Calio, and R. Yarchoan Relative potency of protease inhibitors in monocytes/ macrophages acutely and chronically infected with human immunodeficiency virus J. Infect. Dis. 178 1998 413 422
28. E. Pesenti, C. Pastore, F. Lillo, A.G. Siccardi, D. Vercelli, and L. Lopalco Role of CD4 and CCR5 levels in the susceptibility of primary macrophages to infection by CCR5-dependent HIV type 1 isolates AIDS Res. Hum. Retroviruses 15 1999 983 987
29. E.F. Plow, T.A. Haas, L. Zhang, J. Loftus, and J.W. Smith Ligand binding to integrins J. Biol. Chem. 275 2000 21785 21788
30. C. Shi, X. Zhang, Z. Chen, K. Sulaiman, M.W. Feinberg, C.M. Ballantyne, M.K. Jain, and D.I. Simon Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1 J. Clin. Invest. 114 2004 408 418
31. M. Stern, J. Savill, and C. Haslett Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response Am. J. Pathol. 149 1996 911 921
32. S. Ugolini, I. Mondor, and Q.J. Sattentau HIV-1 attachment: another look Trends Microbiol. 7 1999 144 149
33. J.P. Xiong, T. Stehle, S.L. Goodman, and M.A. Arnaout New insights into the structural basis of integrin activation Blood 102 2003 1155 1159
34. T. Zhu, D. Muthui, S. Holte, D. Nickle, F. Feng, S. Brodie, Y. Hwangbo, J.I. Mullins, and L. Corey Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy J. Virol. 76 2002 707 716